Arvinas (ARVN) Revenue (2017 - 2026)
Arvinas (ARVN) posted Revenue of $249.7 million for Q2 2026, compared with $22.4 million a year earlier.
Powered by 
Analysis
Arvinas (ARVN) Revenue (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Arvinas was $316.7 million, down 15.0% year-over-year; for FY2025, it came in at $262.6 million, down 0.3% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 58.9% (FY2020 to FY2025).
- In prior years, Arvinas' Revenue was $263.4 million in FY2024 (+235.5%), $78.5 million in FY2023 (-40.3%), $131.4 million in FY2022 (+145.1%) and $53.6 million in FY2021 (+106.9%).
- The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q1 2017.
- On a year-over-year basis, Revenue increased in two of the last six quarters, with growth averaging 89.5%.
- The strongest year-over-year quarter for Revenue in the past five years was Q1 2025, with growth of 646.2%; the weakest was Q1 2026, with a decline of 91.7%.
- According to Business Quant data, Revenue for the three prior quarters was $15.6 million (Q1 2026), $9.5 million (Q4 2025) and $41.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Arvinas | 505.42 Mn | -2.15 Bn | - | 249.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249.70 Mn |
| Mar 31, 2026 | 15.60 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 41.90 Mn |
| Jun 30, 2025 | 22.40 Mn |
| Mar 31, 2025 | 188.80 Mn |
| Dec 31, 2024 | 59.20 Mn |
| Sep 30, 2024 | 102.40 Mn |
| Jun 30, 2024 | 76.50 Mn |
| Mar 31, 2024 | 25.30 Mn |
| Dec 31, 2023 | -43.10 Mn |
| Sep 30, 2023 | 34.60 Mn |
| Jun 30, 2023 | 54.50 Mn |
| Mar 31, 2023 | 32.50 Mn |
| Dec 31, 2022 | 37.80 Mn |
| Sep 30, 2022 | 33.20 Mn |
| Jun 30, 2022 | 33.80 Mn |
| Mar 31, 2022 | 26.50 Mn |
| Dec 31, 2021 | 33.20 Mn |
| Sep 30, 2021 | 9.30 Mn |
API Access
Arvinas Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();